Background
Sepsis is associated with high morbidity and mortality. Worldwide, sepsis represents a major health concern in patients in intensive care units (ICU). Notably, the incidence of sepsis has risen in the last decades [
1‐
3], causing a substantial clinical and economic burden to healthcare systems [
4,
5]. Globally, in 2012, 29.5% of patients admitted to the ICU experienced sepsis and ICU mortality rates in patients with sepsis were 29.8% [
6,
7], while hospital mortality rates were 35.3% [
6]. In 2017, the Global Burden of Diseases, Injuries and Risk Factors Study reported 49 million cases of sepsis and 11 million sepsis-related deaths, which accounted for approximately 19.7% of all deaths worldwide [
8]. In 2015, the standardized sepsis-related mortality rate in China was 66.7 deaths per 100,000 population, resulting in an estimated 1 million sepsis-related deaths [
9]. Long-term epidemiological investigations on sepsis in China are limited. The objective of this study was to evaluate the epidemiology of sepsis in secondary and tertiary hospitals in Beijing between 2012 and 2018 using information derived from the Beijing Public Health System. Comparisons of the epidemiological characteristics, hospitalization and prognosis of sepsis among minors, adults and the elderly will help hospitals provide medical services that optimize length of stay, patient outcomes, and cost of hospitalization.
Discussion
This study used the Beijing Public Health System to access hospital homepage databases and to evaluate the epidemiology of sepsis in secondary and tertiary hospitals in Beijing between 2012 and 2018. The study included patients who had a diagnosis of sepsis or an associated condition according to ICD-10-CM codes. The median age of the study population was 60 (50, 81) years and 58.1 % were males. This age and gender distribution is similar to other studies investigating the epidemiology of sepsis in China [
12]. Our findings showed that the proportion of patients with sepsis treated in tertiary hospitals or who received blood transfusion decreased with age, while the proportion of patients who were male, received ventilation or took TCM, and in-hospital mortality and hospitalization cost, increased with age.
The proportion of patients with sepsis treated in tertiary hospitals decreased with age from 99.9% of minors to 78.1% of the elderly. This may be related to different expectations of patients and their families around outcomes. Younger patients, especially minors, are expected to have a good prognosis. The prognosis for elderly patients may not be so good, so patients and families may choose the less invasive treatments provided by secondary hospitals, or palliative care.
A meta-analysis indicated that TCM combined with conventional treatment can improve the prognosis of patients with sepsis [
13‐
15]. Statistics show the number of hospital beds in Beijing for patients is 6.85 per 1,000 population [
16], while the number of hospital beds for patients treated with TCM is 10.48 per 10,000 population [
17], accounting for only one sixth of the total. In this study, 54.4% of patients received TCM; thus, it can be inferred that many physicians in hospitals providing Western medical services also used TCM, and a combination of TCM and Western medicine was commonly used when treating sepsis.
A previous study showed the 77.4% of patients with sepsis in the ICU of a tertiary hospital in China were on mechanical ventilation [
18]. One epidemiological study in Beijing showed that the 13.8% of hospitalized patients with sepsis were admitted to the ICU [
12]. In the present study, ventilation was only used in 26.6% of patients, most often in elderly patients. Taken together, these data suggest that a large number of patients with sepsis in China are treated in general wards without mechanical ventilation. Critical care physicians may not be sufficiently aware of sepsis, which may lead to inappropriate clinical decision-making and an increase in sepsis-related mortality.
In previous studies, mortality rates for sepsis and severe sepsis in developed countries were 17% and 26%-33.2%, respectively [
19,
20]. In low- and middle-income countries, mortality rates for sepsis and severe sepsis were 21.9%-47.3%, and reached 45.6%-52.2% for septic shock [
21‐
25]. In a multicenter study in Asia, in 2009, the ICU mortality rate for severe sepsis was 44.5% [
26]. In China, in 2014 and 2015, ICU mortality rates for sepsis and septic shock were 13.1% and 39.0%, respectively, and the hospital mortality rate for sepsis was 33.0% [
18]. Similarly, in the present study, the in-hospital mortality rate for sepsis was 31.7%, and increased with age from 4.8% in minors to 58.1% in the elderly. Consistent with these findings, a multicenter study conducted in 2019 in southwest China involving 10,598 children (aged 29 days -18 years) reported the in-hospital mortality rate for severe sepsis and septic shock was 18.8% [
27], and a retrospective cohort study of patients with sepsis admitted to public hospitals in Yuetan Subdistrict, Beijing between 2012 and 2014 showed a significant increase in sepsis mortality from 2.4% in patients < 50 years to 30.7% in patients > 90 years [
12]. Sepsis mortality depends on factors such as age, race, gender, comorbidities, and degree of organ dysfunction [
28]. In China, sepsis mortality is expected to increase with the move towards an aging society and the higher prevalence of comorbidities in elderly individuals.
Globally, mortality associated with sepsis is decreasing by year. Severe sepsis 28-day mortality decreased from 46.9% in 1991-1995 to 29% in 2006-2009 in the US [
20], and from 56% in 1993 to 35% in 2001 in France [
29]. Absolute mortality in severe sepsis decreased from 35.0% in 2000 to 18.4% in 2012 in ICUs in Australia and New Zealand [
30]. Hospital mortality fell from 23.7% in 2008 to 19.7% in 2012 in patients with sepsis in all acute-care hospitals in Catalonia [
31]. In contrast, the present study showed an increase in in-hospital mortality in patients with sepsis in China. Long-term epidemiological investigations of sepsis-related mortality in China are limited. However, two multicenter, prospective cohort studies reported that in- hospital mortality in patients with sepsis in China was 33.5% in 2009 [
32] and 33.0% in 2014-2015 [
18]. The disparate findings between studies may be explained by 1) the use of different definitions of sepsis. Our study used Sepsis-3.0, while the prior studies used Sepsis1.0 or 2.0 [
33]; 2) Guidelines for sepsis have evolved since the prior studies were performed [
21,
22,
34]; and 3) rates of mechanical ventilation use in sepsis vary, which may influence sepsis-related mortality.
The cost of sepsis may reflect factors such as the Gross Domestic Product (GDP), regional economy, and public opinion of health. In the US, between 1979 and 2000, the cost of sepsis was an estimated $50,000 per patient, resulting in an annual economic burden of $17 billion [
35]. Between 2003 and 2007, the economic burden of sepsis in the US increased from $15.4 billion to $24.3 billion [
36]. In the UK, in 2002, the cost of sepsis was £25,000 per patient [
7]. In contrast, in India, in 2005, the cost of care for sepsis in the ICU was approximately $200 a day [
37]. The cost of sepsis in China is not as high as that of developed countries. In 2007, the average ICU cost for sepsis in China was $11,390 per patient, or $502 per patient per day [
38]. In our study, median hospitalization cost for all patients was ¥29,453 (15,011, 65,237), and costs increased with age, reaching ¥41,215 (18,991, 88,259) in the elderly. Hospitalization cost showed no significant change from 2012 to 2016, but increased in 2017 and 2018.
Strengths and limitations
Currently, high-quality epidemiological studies on sepsis in China include data collected over 2-20 months [
9,
12,
18,
27,
32]. To the authors’ knowledge, the present study is the longest (7 years) epidemiological investigation of sepsis in secondary and tertiary hospitals in Beijing, using information from 2012-2018 that was derived from the Beijing Public Health System. Information was collated and manually screened to ensure patients with multiple hospitalizations were not overrepresented, which may have biased our findings towards reduced length of hospital stay, in-hospital mortality, and hospitalization cost. The data used in this study were easy and cost-effective to access, and findings provide important information for clinicians and policy makers.
Despite, these strengths, the study was associated with several limitations. First, the data informing this study were acquired from hospitals in Beijing, which may restrict the generalizability of our results across other regions, including those with a lower level of economic development and fewer medical resources. Second, sources of error in retrospective studies include incomplete or missing data. Consequently, the clinical and economic burden of sepsis in China may be more serious than expected; however, our results can be used as a reference for future studies.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.